November 20, 2015

With the U.S. Treasury announcing plans to crack down on tax-inversion deals on Thursday, pharmaceutical giants Pfizer and Allergen have accelerated their merger talks, according to reports. The potential $150 billion deal could see Pfizer redomicile in Ireland. (Reuters)

November 17, 2015

Leading nutrition bar maker thinkThin will be acquired by nutrition company Glanbia in a $217 million deal. 

November 17, 2015

One of the most important takeaways from this morning's result announcement is the improvement in U.S. operations, Doug McMillon, Walmart president and CEO, told analysts Tuesday morning. 

November 13, 2015

Perrigo’s shareholders did not tender a majority of the company’s shares to Mylan by 8 a.m. EST Friday, effectively ending Mylan’s acquisition attempt. 

November 11, 2015

Ahold USA's total third quarter net sales of $5.6 billion were up 16.6%.

November 11, 2015

Carbonated soft drinks have taken a back-seat to other beverage categories as consumers look to flavored still and sparkling waters with a lower calorie count and a healthier profile.

November 11, 2015

Lead by incredible 60% growth in the brow segment, the eye category has been a bright spot for mass market retailers.

November 11, 2015

Sales in the cookie category may be flat overall, but Mondelez’s Oreo brand is on fire and is outpacing category growth with a more than 9% leap in dollar sales.

November 11, 2015

The Bellingham, Wash. Herald is reporting that bankrupt grocery chain Haggen filed papers on Monday that included a plan and timeline for selling its most valuable stores, with an auction tentatively scheduled for Jan. 8. A hearing to discuss the plan has been scheduled for Dec. 4. “Despite the filing, Haggen does not anticipate any changes to continuing operations at the core stores including regular payments to suppliers and partners,” a statement from Haggen said. (Bellingham Herald)

November 11, 2015

Roundy's reports 7.5% net sales decrease across Wisconsin markets, but in Illinois net sales are up 15.9%. 

November 11, 2015

For the 39-week period ended Sept. 26, 2015, Weis Markets' sales increased 3.9% to $2.1 billion,

November 10, 2015

The Seattle Times is reporting that, according to court documents filed last week, Albertsons currently bidding on 36 of 95 stores being sold by the now-bankrupt Haggen. Albertsons had previously sold 146 stores to Haggen as part of its acquisition of Safeway. [Seattle Times]

November 6, 2015

Based on the company’s presentation accompanying a conference call on the acquisition, AstraZeneca’s focus to be on the treatment ZS Pharma is developing for hyperkalemia, a side effect of chronic kidney disease,

November 6, 2015

Novira is a company working on curative treatments for chronic hepatitis B. 

November 6, 2015

The two companies on Friday announced a development and commercialization deal for sotagliflozin, which is currently in development and undergoing Phase 3 trials. 

November 5, 2015

Though Costco’s U.S. sales saw a 1% increase over both the four weeks and nine weeks ended Nov. 1 compared to last year, its Canadian stores saw an 8% decrease in comparable sales. 

November 5, 2015

As the company heads into the holiday season and Q4, CEO Jerry Shore said Fred’s is aiming to optimize its operations and finish the fiscal year with a strong financial showing. 

November 3, 2015

With the completion of this step all Mylan needs is word from Perrigo’s shareholders on whether or not they will accept the company’s $27 billion acquisition offer, which was tendered on Sept. 14. 

November 2, 2015

First-quarter revenue for the Pharmaceutical segment increased 19% to $25.1 billion due to growth from existing and new customers and, to a lesser extent, contributions from acquisitions. 

November 2, 2015

Publix sales for the first nine months of 2015 were $24.1 billion, a 6.4% increase. Comparable-store sales for the first nine months of 2015 increased 4.5%.

November 2, 2015

The New York Times is reporting that Irish pharmaceutical company Shire has entered into an agreement to purchase Dyax, a biotechnology company that makes treatements for hereditary angioedema (HAE), for as much as $6.5 billion. “This highly complementary transaction aligns with and accelerates our strategy to build a global leading biotechnology company focused on rare diseases and specialty conditions,” Shire’s CEO Dr. Flemming Ornskov said. “It adds to our portfolio of best-in-class therapies addressing unmet needs in our core therapeutic areas, expanding and extending our leadership position in HAE.” (New York Times)

October 30, 2015

"Competition is essential in every part of our economy, and especially so in a market as complex and important as health care," Sen. Mike Lee, R-Utah, said about Walgreens’ planned acquisition of Rite Aid. 

October 30, 2015

CVS Health's pharmacy same-store sales were up 4.6% and pharmacy same-store prescription volumes up 4.4% on a 30-day equivalent basis. 

October 30, 2015

“Our customers have different expectations of us today, and we need to meet those expectations," Wakefern chairman and CEO Joseph Colalillo told Wakefern's shareholders. “We are going to deliver that customer experience by uniting around our purpose and bringing our values to life in our stores.”